VSTM - Verastem whipsaws after updates for cancer drug combo
2024-05-24 08:28:58 ET
More on Verastem
- Verastem stock rallies on positive data for pancreatic cancer drug combo
- Verastem gets FDA orphan drug status for low-grade ovarian cancer therapy
- Seeking Alpha’s Quant Rating on Verastem
- Historical earnings data for Verastem
- Financial information for Verastem